Kindstar Globalgene Technology (HKSE:09960) Purchase Of Business : HK$0 Mil (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Kindstar Globalgene Technology Purchase Of Business?

Kindstar Globalgene Technology's purchase of business for the six months ended in Dec. 2023 was HK$0 Mil. It means Kindstar Globalgene Technology spent HK$0 Mil on purchasing business. Kindstar Globalgene Technology's purchase of business for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0 Mil.

Compared with last quarter (HK$0 Mil in Jun. 2023 ), Kindstar Globalgene Technology spent the same money on purchasing business in Dec. 2023 (HK$0 Mil).

Kindstar Globalgene Technology Purchase Of Business Historical Data

The historical data trend for Kindstar Globalgene Technology's Purchase Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kindstar Globalgene Technology Purchase Of Business Chart

Kindstar Globalgene Technology Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Purchase Of Business

Get a 7-Day Free Trial

-2.08

-13.61

-9.40

-1.17

Kindstar Globalgene Technology Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Purchase Of Business	Get a 7-Day Free Trial					-12.45	-9.24	-0.60	-	-

Kindstar Globalgene Technology Purchase Of Business Calculation

The amount used to purchase business.

Purchase Of Business for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0 Mil.

Kindstar Globalgene Technology Purchase Of Business Related Terms

Thank you for viewing the detailed overview of Kindstar Globalgene Technology's Purchase Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.

Kindstar Globalgene Technology (HKSE:09960) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Kindstar Globalgene Technology Inc (HKSE:09960) » Definitions » Purchase Of Business

Comparable Companies

Traded in Other Exchanges

N/A

Address

Biolake D2-1, 666 Gaoxin Road, East Lake High Tech Zone, Hubei Province, Wuhan, CHN

Website

https://www.kindstar.com.cn

Kindstar Globalgene Technology Inc is principally engaged in the provision of clinical testing services. It organizes the business into nine segments, including hematology testing, genetic disease and rare disease testing, infectious disease testing, oncology testing, neurology testing, maternity-related testing, COVID-19-related testing, routine testing, and Other segment provides Testing services for R&D projects and others and miscellaneous services.

Executives

Jackson Hole Trust Company
Huang Bo
Kernelstar Limited	2301 Trustee
Kastle Limited	2301 Trustee
Guo Gui-rong	2202 Interest of your spouse
Huang Shiang	2101 Beneficial owner
Huang Zuie-chin	2101 Beneficial owner
Tu Zanbing
Chan Tan Ching Fen	2307 Founder of a discretionary trust who can infl
Ningbo Meishan Bonded Port Zone Ruifu Bojian Investment Management Co., Ltd.
Cpechina Fund Iii, L.p.	2201 Interest of corporation controlled by you
Cpe Holdings Limited	2201 Interest of corporation controlled by you
Cpe Holdings International Limited	2201 Interest of corporation controlled by you
Cpe Funds Iii Limited	2201 Interest of corporation controlled by you
Ck Lab Tech Investment Limited	2101 Beneficial owner

Kindstar Globalgene Technology (HKSE:09960) Headlines

No Headlines